Parallel Advisors, LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1690010 SAN FRANCISCO, CA

Position in CRNX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$34,164

+$1,004 QoQ

Shares Held

913

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#207

of 266 holders

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. CRNX ranks #55 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CORT	Corcept Therapeutics Inc	3,962,177	$344,511,290
2	VRTX	Vertex Pharmaceuticals Inc / Ma	5,389	$2,676,877
3	RCUS	Arcus Biosciences, Inc.	86,557	$2,668,552
4	REGN	Regeneron Pharmaceuticals, Inc.	1,063	$662,823
5	KRYS	Krystal Biotech, Inc.	1,699	$631,467
6	ARGX	Argenx SE	640	$593,772
7	INCY	Incyte Corp	4,961	$562,378
8	VKTX	Viking Therapeutics, Inc.	13,833	$539,625

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$34,164	913	0.0%	Shares	Sole	2026-08-05
2026-03-31	$33,160	913	-25.5%	Shares	Sole	2026-05-07
2025-12-31	$57,023	1,225	+34.6%	Shares	Sole	2026-02-11
2025-09-30	$37,901	910	-8.7%	Shares	Sole	2025-11-13
2025-06-30	$28,673	997	-35.6%	Shares	Sole	2025-07-08
2025-03-31	$51,953	1,549	+3.3%	Shares	Sole	2025-04-08
2024-12-31	$76,643	1,499	+0.7%	Shares	Sole	2025-02-10
2024-09-30	$76,087	1,489	0.0%	Shares	Sole	2024-11-13
2024-06-30	$66,692	1,489	-4.1%	Shares	Sole	2024-08-08
2024-03-31	$72,649	1,552	+253.5%	Shares	Sole	2024-05-06
2023-12-31	$15,619	439	+7216.7%	Shares	Sole	2024-02-12
2022-09-30	$117	6	0.0%	Shares	Sole	2022-11-10
2021-09-30	$126	6	—	Shares	Sole	2021-11-02
No filing history on record for this holder in this stock.